Vallersnes Odd Martin, Persett Per Sverre, Øiestad Elisabeth Leere, Karinen Ritva, Heyerdahl Fridtjof, Hovda Knut Erik
a Department of General Practice , University of Oslo , Oslo , Norway.
b Oslo Accident and Emergency Outpatient Clinic, City of Oslo Health Agency , Oslo , Norway.
Clin Toxicol (Phila). 2017 Aug;55(7):636-644. doi: 10.1080/15563650.2017.1312002. Epub 2017 Apr 13.
Recreational drug toxicity is frequent. Availability of new psychoactive substances is steadily increasing. However, data with verified analyses from clinical settings are limited. To evaluate the impact of novel psychoactive substances (NPS) on recreational drug toxicity in Oslo, Norway, we analysed samples from a selection of patients.
All the patients presenting with recreational drug toxicity at the Oslo Accident and Emergency Outpatient Clinic (OAEOC) and at the Oslo University Hospital (OUH) were registered from April through September 2014. Oral fluid samples were collected at the OAEOC. Blood samples were collected at the OUH. The samples were screened using ultra-high performance liquid chromatography - tandem mass spectrometry (UHPLC-MS/MS).
Nine hundred and sixty-four cases were included, 841 (87.2%) at the OAEOC and 123 (12.8%) at the OUH. A total of 55 oral fluid samples (OAEOC) and 103 blood samples (OUH) could be analysed. NPS were not clinically suspected in any of the screened cases. At the outpatient clinic, the most commonly found substances were clonazepam in 42/55 (76.4%) cases, amfetamines in 40/55 (72.7%) and heroin in 39/55 (70.9%). In seven (12.7%) cases NPS were detected: 4-methylamfetamine in three cases, dimethyltryptamine in two, methylone in one, and N,N-dimethyl-3,4-methylenedioxyamfetamine in one. Among the hospital patients, the most commonly found substances were clonazepam in 51/103 (49.5%) cases, amfetamines in 48/103 (46.6%), heroin in 31/103 (30.1%), and diazepam in 30/103 (29.1%). In five (4.9%) cases NPS were detected: JWH-210 in two cases, AM-2201 in two, and 5-EAPB in one.
NPS were clinically not suspected, though found in eight percent of cases. Still, the vast majority of patients treated for recreational drug toxicity in Oslo have taken classical drugs. Management of these patients should be based on their clinical condition. However, it is highly important to be alert to atypical presentations possibly resulting from unsuspected drugs.
娱乐性药物中毒很常见。新型精神活性物质的可得性在稳步增加。然而,来自临床环境的经过验证分析的数据有限。为了评估新型精神活性物质(NPS)对挪威奥斯陆娱乐性药物中毒的影响,我们分析了部分患者的样本。
2014年4月至9月期间,对所有在奥斯陆事故与急诊门诊(OAEOC)以及奥斯陆大学医院(OUH)出现娱乐性药物中毒的患者进行了登记。在OAEOC采集口腔液样本。在OUH采集血液样本。使用超高效液相色谱 - 串联质谱法(UHPLC-MS/MS)对样本进行筛查。
共纳入964例病例,其中841例(87.2%)在OAEOC,123例(12.8%)在OUH。总共可以分析55份口腔液样本(OAEOC)和103份血液样本(OUH)。在任何筛查病例中临床均未怀疑有NPS。在门诊,最常检测到的物质是氯硝西泮,42/55例(76.4%);苯丙胺,40/55例(72.7%);海洛因,39/55例(70.9%)。在7例(12.7%)病例中检测到NPS:3例4 - 甲基苯丙胺,2例二甲基色胺,1例甲烯二氧吡咯戊酮,1例N,N - 二甲基 - 3,4 - 亚甲基二氧基苯丙胺。在住院患者中,最常检测到的物质是氯硝西泮,51/103例(49.5%);苯丙胺,48/103例(46.6%);海洛因,31/103例(30.1%);地西泮,30/103例(29.1%)。在5例(4.9%)病例中检测到NPS:2例JWH - 210,2例AM - 2201,1例5 - EAPB。
尽管在8%的病例中发现了NPS,但临床未怀疑有NPS。不过,在奥斯陆接受娱乐性药物中毒治疗的绝大多数患者服用的是传统药物。对这些患者的管理应基于其临床状况。然而,警惕可能由未被怀疑的药物导致的非典型表现非常重要。